Picture of Consun Pharmaceutical logo

1681 — Consun Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Consun Pharmaceutical Group Posts FY Profit Attributable Of RMB79.8 Mln

March 23 (Reuters) - Consun Pharmaceutical Group Ltd
 1681.HK :
    * BOARD PROPOSED TO DECLARE A FINAL DIVIDEND OF HKD0.10 PER
SHARE
    * FY REVENUE DOWN 6.3% TO RMB1.73 BILLION
    * PROFIT FOR YEAR ATTRIBUTABLE RMB79.8 MLN, DOWN 82.8%
    * ESTIMATED TRIAL PRODUCTION OF HUASHENGXIAN TO BE COMPLETED
IN
2020 & WILL APPLY FOR COMMENCEMENT OF CLINICAL STUDY
    * OFFERS TREATMENTS FOR RESPIRATORY DISEASES, HENCE HAS
OPTIMISTIC
OUTLOOK FOR CHINESE MEDICINE MARKET & CHINESE MEDICINE COS

Source text for Eikon:  ID:nHKS7h7m3p 
Further company coverage:  1681.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Consun Pharmaceutical

See all news